Cannabis Law Report

JUNE 16, 2023

On this page, you can find the latest analysis of the drug situation for cannabis in Europe, including prevalence of use, treatment demand, seizures, price and purity, harms and more. This page is part of the European Drug Report 2023, the EMCDDA’s annual overview […]

Treatment 52

Treatment Cannabis Compliance Compliance 52

Project CBD

MAY 10, 2023

A March 2023 paper in the journal Biological Psychiatry 1 adds to the discourse by reporting that in a placebo-controlled study of 40 healthy male volunteers, microdosing LSD improved self-reported ratings of creativity, connectedness, energy, happiness, irritability, and wellness on dose days relative to non-dose days.

Microdosing 186

Microdosing Research and Development Treatment Therapy 186

Cannabis Law Report

FEBRUARY 8, 2023

Authored by: Suzy Madar , Matthew Swinn , Rosie Rand and Tim Craven On 3 February 2023, the Therapeutic Goods Administration (TGA) announced a major regulatory shift that will have significant impacts for the treatment of mental health conditions. 1] In our recent article, we explored the most […]

Treatment 52

Treatment Law Conditions Medicine 52

Project CBD

JUNE 7, 2023

Writing in the International Journal of Molecular Sciences in March 2023, 4 the researchers note that not only did they observe improvements in diseased liver cells, but they also confirmed through the use of specific receptor antagonists that these changes were indeed mediated by CB2 and two PPAR receptor types: PPAR-alpha and PPAR-gamma.

Terpenes 227

Terpenes Chronic Pain Cannabinoids Food 227

TheAnswerPage

APRIL 24, 2023

According to a study appearing in a Jan 2023 JAMA Network publication, “Among adults with chronic pain in states with medical cannabis laws, 3 in 10 persons reported using cannabis to manage their pain. Use of Cannabis and Other Pain Treatments Among Adults With Chronic Pain in US States With Medical Cannabis Programs.

Chronic Pain 52

Chronic Pain Treatment Programs Law 52

TheAnswerPage

MARCH 20, 2023

Has the use of a transdermal gel for regional and systemic delivery of CBD been evaluated for the treatment of epilepsy? A transdermal gel for regional and systemic delivery of CBD (Zynerba Pharmaceuticals) is in clinical development for treatment of epilepsy, developmental and epileptic encephalopathy, fragile-X syndrome, and osteoarthritis.

Epilepsy 52

Epilepsy Topical Safety Treatment 52

United Patients Group

APRIL 11, 2023

In 2023, health education will continue to be of utmost importance as the world grapples with a multitude of health challenges. In this blog, we will explore the top 8 health degrees that will be in demand in 2023, providing a comprehensive overview of each degree’s requirements and potential career paths.

Education 52

Education Research and Development Therapy Programs 52

Medical Marijuana Program Connection

MARCH 13, 2023

MONDAY, March 13, 2023 (HealthDay News) — An approved CBD oil product will, apparently, not be the solution for patients. Read More

Oil 52

Oil Treatment CBD Patients 52

Cannabis Law Report

MARCH 29, 2023

NJ, March 27, 2023 (GLOBE NEWSWIRE) — Silo Pharma, Inc. Nasdaq: SILO) (the “Company”), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced that it has filed a provisional patent application titled “Methods and Compositions for Pain Management.”

Treatment 52

Treatment 52

Cannabis Law Report

FEBRUARY 14, 2023

13, 2023 (GLOBE NEWSWIRE) — Silo Pharma, Inc. Patent application covers use of novel homing peptides to reduce toxicity and advance payload of therapeutic ENGLEWOOD CLIFFS, NJ, Feb.

Treatment 52

Treatment 52

Veriheal

JULY 9, 2021

For the past 25 years, Desouza has been investigating the world of cannabinoid treatment options. As per terms of the new law, residents can grow their own buds from July 2023; no more than six plants per person and 12 per household. His most recent bout of research is already two years deep.

Treatment 52

Treatment Research and Development Consumption Sleep 52

Veriheal

JANUARY 16, 2024

A recent 2023 study published in the prestigious journal Orthopedics suggests cannabidiol (CBD) is becoming quite popular among families of children with cerebral palsy (CP) – indicating that nature’s plant may be doing some serious good for those who need it most. Treatment plans are customized to each individual’s needs.

Patients 113

Patients CBD Treatment Research and Development 113

Medical Marijuana Program Connection

JUNE 29, 2023

CBD oil has gained popularity in recent years as a potential treatment… var mantis = mantis || []; mantis.push(['display', 'load', { property: '5bbb53a2bcafb20075d8dc64' }]); Disclaimer: This post contains affiliate links.

Epilepsy 52

Epilepsy Oil CBD Treatment 52

Cannabis Law Report

AUGUST 12, 2022

Marijuana Moment report on some of the panels being proposed for 2023…… Voting is now open for the public to decide which panels will make the stage at next year’s South By Southwest (SXSW) festival—and there are about 100 marijuana- and psychedelics-related proposals to pick from. Which Political Party Will Legalize Weed?

Research and Development 52

Research and Development Events Topical Policy 52

Medical Marijuana Program Connection

MAY 23, 2023

DehydraTECH-CBD offers distinctive mechanistic benefits related to its growing therapeutic utility KELOWNA, BC / ACCESSWIRE / May 23, 2023 /. Read More

Treatment 40

Treatment CBD 40

Cannabis Law Report

APRIL 19, 2023

Here’s the blurb With research showing that psychedelics hold substantial promise for the treatment of mental health conditions such as depression, PTSD and addiction, PSYCH Symposium provides a platform for decision makers to accelerate the development and delivery of these medicines.

Research and Development 52

Research and Development Events Treatment Policy 52

Medical Marijuana Program Connection

JANUARY 30, 2024

BORDEAUX, France–(BUSINESS WIRE)–Regulatory News: Aelis Farma (ISIN: FR0014007ZB4 – Ticker: AELIS), a clinical-stage biopharmaceutical company specializing in the development of treatments for brain diseases, today announces its indicative financial calendar for the financial year 2024.

Events 53

Events Treatment Business 53

TheAnswerPage

APRIL 28, 2023

Do most people who use cannabis as part of their pain management regime find that the use of cannabis has led to an increase or decrease in the use of NON-pharmacologic treatments? Use of Cannabis and Other Pain Treatments Among Adults With Chronic Pain in US States With Medical Cannabis Programs. JAMA Netw Open. 2023;6(1):e2249797.

Chronic Pain 52

Chronic Pain Treatment Programs Cannabis 52

Veriheal

JANUARY 15, 2024

2023 World UN World Drug Report The 2023 World Drug Report urges the development of effective drug policies. The 2023 World Drug Report shows unreasonable use of criminal penalties for the “war on drugs” movement as it discourages people who use drugs for treatment, and this encourages social stigma.

Policy 117

Policy Research and Development Collective Law 117

Veriheal

FEBRUARY 8, 2024

A new collective bargaining agreement between the NBA and the National Basketball Players Association union went into effect July 1, 2023. Now, with the 2023 policy change, the league will also no longer punish players for cannabis use. This agreement now allows players to consume cannabis outside of games without penalty.

Advocacy 112

Advocacy Chronic Pain Policy Cannabis 112

TheAnswerPage

MAY 12, 2023

This oral CBD solution is indicated for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC) in one year of age and older, but has not been approved for other seizure disorders. True or false? The FDA has approved a CBD product derived from marijuana (not hemp).

Treatment 59

Treatment Hemp CBD Marijuana 59

Medical Marijuana Program Connection

NOVEMBER 24, 2023

.–(BUSINESS WIRE)–Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment. Read More

Treatment 59

Treatment Business 59

TheAnswerPage

APRIL 26, 2023

Yes, they did – In addition to using cannabis and other pharmacologic agents, most people also reported having used nonpharmacologic pain treatment (70.6%). Use of Cannabis and Other Pain Treatments Among Adults With Chronic Pain in US States With Medical Cannabis Programs. Bicket MC, Stone EM, McGinty EE. JAMA Netw Open.

Chronic Pain 52

Chronic Pain Treatment Programs Cannabis 52

Veriheal

NOVEMBER 9, 2023

Traditional treatments for these conditions often involve medication, physical therapy, or more invasive interventions like surgery. A new 2023 study published in the journal Medical Cannabis and Cannabinoids revealed that using a THC/CBD spray can help significantly reduce chronic back and neck pain. How Does Cannabis Spray Work?

Treatment 109

Treatment Therapy Research and Development THC 109

Veriheal

MARCH 20, 2023

Using psilocybin in small doses, or microdosing, has been shown to aid in the treatment of various mental health issues, including anxiety, depression, PTSD, and obsessive-compulsive disorder. Smith cited results from clinical trials showing that MDMA holds promise in the treatment of PTSD. Connecticut Gov. Minnesota Rep. Missouri Rep.

Clinical Trials 98

Clinical Trials Therapy Decriminalization Treatment 98

Cannabis Law Report

APRIL 19, 2023

April 18, 2023 Awakn Life Sciences Signs Collaboration Agreement With University of Exeter for Upcoming Phase III Trial Phase III Trial will Assess Ketamine-Assisted Therapy for The Treatment of Severe Alcohol Use Disorder TORONTO, CANADA, 18 April, 2023 – Awakn Life Sciences Corp.

Therapy 52

Therapy Treatment 52

TheAnswerPage

APRIL 18, 2023

Does short-term treatment with THC-rich cannabis induce clinical remission and improve quality of life in patients with mild to moderately active ulcerative colitis? Yes, according to a recent study. Cannabis is associated with clinical but not endoscopic remission in ulcerative colitis: A randomized controlled trial.

Treatment 52

Treatment THC Patients Cannabis 52

Medicinal Genomics

FEBRUARY 8, 2024

In November 2023, the CDC reported a fatal occupational asthma attack suffered by an employee at a Massachusetts cannabis production facility. We also know that there is a growing number of cannabis cultivators who are using remediation techniques (irradiation, ozone treatment, acid treatment, hydrogen peroxide treatment, etc.)

Treatment 98

Treatment Dispensary Safety Conditions 98

TheAnswerPage

MAY 16, 2023

Studies have suggested that some cannabinoids effectively reduce the spasticity associated with multiple sclerosis, and, in fact, the federal drug agencies of several countries (but not the US) have approved a cannabinoid-based formula (50:50 THC:CBD) called Sativex (nabiximols) for the treatment of severe spasticity in multiple sclerosis.

Cannabinoids 59

Cannabinoids Extraction Treatment Medicine 59

Veriheal

SEPTEMBER 1, 2023

Open showdown, and the Native Coalition of Colorado calls for healing rather than profit at Denver’s Psychedelic Science 2023 conference. Of course, this kind of treatment needs to be done under the care of a qualified physician. Let’s dive into this week’s canna-news. Let us know in the comments! The reason?

Therapy 109

Therapy Treatment Cannabis Patients 109

Cannabis Law Report

APRIL 17, 2023

April 17, 2023 Press Release WASHINGTON, D.C. –

Business 52

Business Treatment Compliance Compliance 52

TheAnswerPage

APRIL 11, 2023

This reduction was more significant in patients who received cannabis-based products prior to treatment with oxaliplatin, suggesting a protective effect. The results of a retrospective study indicated that the rate of neuropathy was reduced among patients treated with cannabis-based therapies and oxaliplatin.

Therapy 52

Therapy Patients Treatment Cannabis 52

TheAnswerPage

APRIL 30, 2023

Use of Cannabis and Other Pain Treatments Among Adults With Chronic Pain in US States With Medical Cannabis Programs. According to a large cross-sectional survey (n= 1661) involving adults with chronic pain who lived in the 36 states (and Washington, DC) with active medical cannabis programs in March to April 2022, “19.1%

Chronic Pain 52

Chronic Pain Programs Treatment Cannabis 52

CannaMD

JULY 11, 2023

An exhaustive study by the American Medical Association (AMA) has confirmed what current medical marijuana patients have stated for quite some time — that medical cannabis treatment improves health-related quality of life for patients with a range of health conditions.

Marijuana 52

Marijuana Conditions Patients Treatment 52

TheAnswerPage

MAY 1, 2023

Use of Cannabis and Other Pain Treatments Among Adults With Chronic Pain in US States With Medical Cannabis Programs. According to a large cross-sectional survey (n= 1661) involving adults with chronic pain who lived in the 36 states (and Washington, DC) with active medical cannabis programs in March to April 2022, “26.0%

Chronic Pain 52

Chronic Pain Therapy Programs Treatment 52

Dykema (Cannabis Law Blog)

APRIL 20, 2023

vi] The 2023 Texas Legislature is advancing legislation that would amend the definition of “low-THC” cannabis to a level more consistent with other states and further expand the scope of conditions that medicinal cannabis treatment may be prescribed. 2 – 3 (2023). Specifically, H.B. Code § 169.001 et seq. [vi] 1805, 88th Leg.,

Law 74

Law Chronic Pain Conditions Medicine 74

TheAnswerPage

APRIL 29, 2023

Use of Cannabis and Other Pain Treatments Among Adults With Chronic Pain in US States With Medical Cannabis Programs. reported that their use of cannabis led to decreased use of physical therapy (5.9% reported it led to increased use),…” Bicket MC, Stone EM, McGinty EE. JAMA Netw Open. 2023;6(1):e2249797.

Chronic Pain 52

Chronic Pain Therapy Programs Treatment 52